Trump plans tariffs on imported generic medicine within two years

U.S. President Donald Trump has declared his intention to implement tariffs on imported generic medicines, aiming to encourage domestic pharmaceutical production. Companies will be given a two-year grace period to build manufacturing plants and facilities within the United States.

According to a post on Trump's social media platform, Truth Social, the current zero percent tariff on generic drugs entering the U.S. will remain in place for the next two years, starting August 1. Following this period, the tariff rate will increase to 100% for one year, and then escalate to 200%.

“

It is done to pull the production of generic medicine into the USA.

Trump stated that this policy is designed to "pull the production of generic medicine into the USA." He characterized the tariffs as a "punishment to those companies that decide not to build factories and production facilities within the specified timeframe they have been given."

Generic drugs, also known as copycat medicines, contain the same active ingredients as their original counterparts but are typically sold at a lower price. This move signals a significant shift in U.S. trade policy regarding pharmaceuticals, prioritizing domestic manufacturing.

“

The tariffs are a punishment to those companies that decide not to build factories and production facilities within the specified timeframe they have been given.